Development and real-life use assessment of a self-management smartphone application for patients with inflammatory arthritis. A user-centred step-by-step approach
BACKGROUND: Mobile health applications (apps) are increasing in interest to enhance patient self-management. Few apps are actually used by patients and have been developed for patients with inflammatory arthritis (IA) treated with disease-modifying anti-rheumatic drugs which use entails risk of adverse effects such as infections.
OBJECTIVE: To develop Hiboot, a self-management mobile app for patients with IA, by using a user-centred step-by-step approach and assess its real-life use.
METHODS: The app development included first a qualitative study with semi-guided audiotaped interviews of 21 patients to identify the impact of IA on daily life and patient treatments practices and an online cross-sectional survey of 344 patients to assess their health apps use in general and potential user needs. A multidisciplinary team developed the first version of the app via five face-to-face meetings. After app launch, a second qualitative study of 21 patients and a users' test of 13 patients and 3 rheumatologists led to the app's current version. The number of app installations, current users and comments were collected from the Google Play store and the Apple store.
RESULTS: The qualitative study revealed needs for counselling, patient-health professional partnership, and skills to cope with risk situations; 86.8% participants would be ready to use an app primarily on their rheumatologist's recommendation. Six functionalities were implemented: a safety checklist before treatment administration, aids in daily life situations based on the French academic recommendations, treatment reminders, global well-being self-assessment, periodic counselling messages, and a diary. The Hiboot app was installed 20,500 times from September 2017 to October 2020, with 4300 regular current users. Scores were 4.4/5 stars at Android and iOS stores.
CONCLUSION: Hiboot is a free self-management app for patients with IA developed by a step-by-step process including patients and health professionals. Further evaluation of the Hiboot benefit is needed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
PloS one - 17(2022), 9 vom: 06., Seite e0272235 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Beauvais, Catherine [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antirheumatic Agents |
|---|
| Anmerkungen: |
Date Completed 19.09.2022 Date Revised 21.09.2022 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.1371/journal.pone.0272235 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346247381 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346247381 | ||
| 003 | DE-627 | ||
| 005 | 20231226030949.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1371/journal.pone.0272235 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1154.xml |
| 035 | |a (DE-627)NLM346247381 | ||
| 035 | |a (NLM)36107954 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Beauvais, Catherine |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Development and real-life use assessment of a self-management smartphone application for patients with inflammatory arthritis. A user-centred step-by-step approach |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.09.2022 | ||
| 500 | |a Date Revised 21.09.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Mobile health applications (apps) are increasing in interest to enhance patient self-management. Few apps are actually used by patients and have been developed for patients with inflammatory arthritis (IA) treated with disease-modifying anti-rheumatic drugs which use entails risk of adverse effects such as infections | ||
| 520 | |a OBJECTIVE: To develop Hiboot, a self-management mobile app for patients with IA, by using a user-centred step-by-step approach and assess its real-life use | ||
| 520 | |a METHODS: The app development included first a qualitative study with semi-guided audiotaped interviews of 21 patients to identify the impact of IA on daily life and patient treatments practices and an online cross-sectional survey of 344 patients to assess their health apps use in general and potential user needs. A multidisciplinary team developed the first version of the app via five face-to-face meetings. After app launch, a second qualitative study of 21 patients and a users' test of 13 patients and 3 rheumatologists led to the app's current version. The number of app installations, current users and comments were collected from the Google Play store and the Apple store | ||
| 520 | |a RESULTS: The qualitative study revealed needs for counselling, patient-health professional partnership, and skills to cope with risk situations; 86.8% participants would be ready to use an app primarily on their rheumatologist's recommendation. Six functionalities were implemented: a safety checklist before treatment administration, aids in daily life situations based on the French academic recommendations, treatment reminders, global well-being self-assessment, periodic counselling messages, and a diary. The Hiboot app was installed 20,500 times from September 2017 to October 2020, with 4300 regular current users. Scores were 4.4/5 stars at Android and iOS stores | ||
| 520 | |a CONCLUSION: Hiboot is a free self-management app for patients with IA developed by a step-by-step process including patients and health professionals. Further evaluation of the Hiboot benefit is needed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Antirheumatic Agents |2 NLM | |
| 700 | 1 | |a Pham, Thao |e verfasserin |4 aut | |
| 700 | 1 | |a Montagu, Guillaume |e verfasserin |4 aut | |
| 700 | 1 | |a Gleizes, Sophie |e verfasserin |4 aut | |
| 700 | 1 | |a Madrisotti, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Lafourcade, Alexandre |e verfasserin |4 aut | |
| 700 | 1 | |a Vidal, Céline |e verfasserin |4 aut | |
| 700 | 1 | |a Dervin, Guillaume |e verfasserin |4 aut | |
| 700 | 1 | |a Baudard, Pauline |e verfasserin |4 aut | |
| 700 | 1 | |a Desouches, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Tubach, Florence |e verfasserin |4 aut | |
| 700 | 1 | |a Le Calvez, Julian |e verfasserin |4 aut | |
| 700 | 1 | |a de Quatrebarbes, Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Lafarge, Delphine |e verfasserin |4 aut | |
| 700 | 1 | |a Grange, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Alliot-Launois, Françoise |e verfasserin |4 aut | |
| 700 | 1 | |a Jeantet, Henri |e verfasserin |4 aut | |
| 700 | 1 | |a Antignac, Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Tropé, Sonia |e verfasserin |4 aut | |
| 700 | 1 | |a Besset, Ludovic |e verfasserin |4 aut | |
| 700 | 1 | |a Sellam, Jérémie |e verfasserin |4 aut | |
| 700 | 0 | |a Therapeutic patient education group of the French Society of Rheumatology and Club Rhumatismes et Inflammations |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t PloS one |d 2006 |g 17(2022), 9 vom: 06., Seite e0272235 |w (DE-627)NLM167327399 |x 1932-6203 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2022 |g number:9 |g day:06 |g pages:e0272235 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1371/journal.pone.0272235 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2022 |e 9 |b 06 |h e0272235 | ||